Staff Publications: March 2017

  1. Arvold ND, Pinnell NE, Mahadevan A, et al. Steroid and Anticonvulsant Prophylaxis for Stereotactic Radiosurgery: Large Variation in Physician Recommendations. Practical radiation oncology. 2016;6(4):e89-96. PMID: 26850650.
  2. Baker N, Tong C, Simhan J. Reconstructive Management Options of Delayed Complications Following Bladder Outlet Surgery. Current urology reports. 2017;18(4):27. PMID: 28247326.
  3. Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Digestive diseases and sciences. 2017. PMID: 28315030.
  4. Bazzoli A, Karanicolas J. “Solvent Hydrogen-Bond Occlusion”: A New Model of Polar Desolvation for Biomolecular Energetics. Journal of computational chemistry. 2017. PMID: 28318014.
  5. Berger ER, Wang CE, Kaufman CS, et al. National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. Journal of the American College of Surgeons. 2017;224(3):236-244.
  6. Bingham C, Fernandez SV, Fittipaldi P, et al. Mutational Studies on Single Circulating Tumor Cells Isolated from the Blood of Inflammatory Breast Cancer Patients. Breast cancer research and treatment. 2017. PMID: 28271309.
  7. Campbell SC, Dong W, Uzzo R, Kutikov A. Re: Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. European urology. 2017;71(3):495-495.
  8. Dong Y, Ruth KJ, Churilla TM, et al. The Need for Androgen Deprivation Therapy in Patients with Intermediate-Risk Prostate Cancer Treated with Dose-Escalated External Beam Radiation Therapy. The Canadian journal of urology. 2017;24(1):8656-8662. PMID: 28263132.
  9. Escudier B, Sharma P, McDermott DF, et al. Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma. European urology. 2017. PMID: 28262413.
  10. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer. 2016;122(9):1349-1369. PMID: 26799932.
  11. Gaponova AV, Deneka AY, Beck TN, et al. Identification of Evolutionarily Conserved DNA Damage Response Genes That Alter Sensitivity to Cisplatin. Oncotarget. 2017;8(12):19156-19171.
  12. Geynisman DM, de Velasco G, Sewell KL, Jacobs I. Biosimilar Biologic Drugs: A New Frontier in Medical Care. Postgraduate medicine. 2017. PMID: 28343424.
  13. Grove M, Kim H, Santerre M, et al. Yap/Taz Initiate and Maintain Schwann Cell Myelination. Elife. 2017;6. PMID: 28124973. PMC5287714.
  14. Haas NB, Manola J, Dutcher JP, et al. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the Assure Randomized Trial. JAMA oncology. 2017. PMID: 28278333.
  15. Haifler M, Kutikov A. Update on Renal Mass Biopsy. Current urology reports. 2017;18(4):28. PMID: 28251484.
  16. Hensley H, Cooper HS, Chang WL, Clapper ML. Imaging Matrix Metalloproteases in Spontaneous Colon Tumors: Validation by Correlation with Histopathology. Methods in molecular biology (Clifton, NJ). 2017;1579:245-255. PMID: 28299741.
  17. Huang Q, He S, Tian Y, et al. Hsp90 Inhibition Destabilizes Ezh2 Protein in Alloreactive T Cells and Reduces Graft-Versus-Host Disease in Mice. Blood. 2017. PMID: 28246193.
  18. Hurwitz MD, Harris J, Sartor O, et al. Adjuvant Radiation Therapy, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of Nrg Oncology/Rtog Study 0621. Cancer. 2017. PMID: 28323339.
  19. Kennedy AS, Ball D, Cohen SJ, et al. Baseline Hemoglobin and Liver Function Predict Tolerability and Overall Survival of Patients Receiving Radioembolization for Chemotherapy-Refractory Metastatic Colorectal Cancer. Journal of gastrointestinal oncology. 2017;8(1):70-80. PMID: 28280611. PMC5334043.
  20. Kennedy PT, Bertoletti A, Mason WS. Reply. Gastroenterology. 2017;152(5):1246-1247. PMID: 28273438.
  21. Korobeynikov V, Deneka AY, Golemis EA. Mechanisms for Nonmitotic Activation of Aurora-a at Cilia. Biochemical Society Transactions. 2017;45(1):37-39. PMID:
  22. Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal Shock Wave Therapy: Current Perspectives and Future Directions. Current urology reports. 2017;18(4):25. PMID: 28247327.
  23. Leroy B, Ballinger ML, Baran-Marszak F, et al. Recommended Guidelines for Validation, Quality Control, and Reporting of Tp53 Variants in Clinical Practice. Cancer research. 2017;77(6):1250-1260. PMID: 28254861.
  24. Liu HL, Huang BY, Zhang MS, Wang HR, Qu YM, Yu CJ. Sellar and Suprasellar Granular Cell Tumor of Neurohypophysis. Chinese medical journal. 2017;130(6):741-743. PMID: 28303860.
  25. LoRusso PM, Infante JR, Kim KB, et al. A Phase I Dose-Escalation Study of Selumetinib in Combination with Docetaxel or Dacarbazine in Patients with Advanced Solid Tumors. BMC cancer. 2017;17(1):173. PMID: 28264648. PMC5340007.
  26. Lynch SM, Mitra N, Ross M, et al. A Neighborhood-Wide Association Study (Nwas): Example of Prostate Cancer Aggressiveness. PloS one. 2017;12(3):e0174548. PMID: 28346484.
  27. Merza H, Bilusic M. Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions. Current oncology reports. 2017;19(4):27. PMID: 28303494.
  28. Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. J Am Coll Surg. 2017;224(4):635-642. PMID: 28214556.
  29. Mustian KM, Alfano CM, Heckler C, et al. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-Analysis. JAMA oncology. 2017. PMID: 28253393.
  30. Naito S, Makhov P, Astsaturov I, et al. Ldl Cholesterol Counteracts the Antitumour Effect of Tyrosine Kinase Inhibitors against Renal Cell Carcinoma. British journal of cancer. 2017. PMID: 28350788.
  31. Necchi A, Pond GR, Raggi D, et al. Clinical Outcomes of Perioperative Chemotherapy in Patients with Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis. Clinical genitourinary cancer. 2017. PMID: 28325636.
  32. Peri S, Caretti E, Tricarico R, et al. Haploinsufficiency in Tumor Predisposition Syndromes: Altered Genomic Transcription in Morphologically Normal Cells Heterozygous for Vhl or Tsc Mutation. Oncotarget. 2017;8(11):17628-17642.
  33. Phelan CM, Kuchenbaecker KB, Tyrer JP, et al. Identification of 12 New Susceptibility Loci for Different Histotypes of Epithelial Ovarian Cancer. Nature genetics. 2017. PMID: 28346442.
  34. Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: Us-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016;23(4):347-358. PMID: 27842324. PMC5321133.
  35. Pollack A, Kwon D, Walker G, et al. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated with Radiotherapy for Prostate Cancer. Jnci-Journal of the National Cancer Institute. 2017;109(2). PMID: WOS:000396774100009.
  36. Prabhu VV, Hong B, Allen JE, et al. Small-Molecule Prodigiosin Restores P53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells Via C-Jun-Mediated Deltanp73 Inhibition and P73 Activation. Cancer research. 2016;76(7):1989-1999. PMID: 26759239.
  37. Raynal NJ, Da Costa EM, Lee JT, et al. Repositioning Fda-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome. Molecular cancer therapeutics. 2017;16(2):397-407. PMID: 27980103. PMC5292054.
  38. Rimm DL, Han G, Taube JM, et al. A Prospective, Multi-Institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for Pd-L1 Expression in Non-Small Cell Lung Cancer. JAMA oncology. 2017. PMID: 28278348.
  39. Ristau BT, Smaldone MC. Kidney Cancer: Emerging Guidelines for Managing Small Renal Masses. Nature reviews Urology. 2017. PMID: 28290457.
  40. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017. PMID: 28325736.
  41. Schrock AB, Li SD, Frampton GM, et al. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017. PMID: 28315738.
  42. Stein MN, Bertino JR, Kaufman HL, et al. First-in-Human Clinical Trial of Oral Onc201 in Patients with Refractory Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28331050.
  43. Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers & Prevention. 2017;26(1):75-84.
  44. Tokar JJ, Warrick JW, Guckenberger DJ, et al. Interrogating Bronchoalveolar Lavage Samples Via Exclusion-Based Analyte Extraction. SLAS technology. 2017:2472630317696780. PMID: 28298147.
  45. Traino HM, Siminoff LA. Keep It Going: Maintaining Health Conversations Using Relational and Instrumental Approaches. Health communication. 2016;31(3):308-319. PMID: 26325602.
  46. van Vulpen M, Wang L. Within the Next Five Years, Adaptive Hypofractionation Will Become the Most Common Form of Radiotherapy. Medical physics. 2016;43(7):3941. PMID: 27370112.
  47. Volokh OI, Derkacheva NI, Studitsky VM, Sokolova OS. [Structural Studies of Chromatin Remodeling Factors]. Molekuliarnaia biologiia. 2016;50(6):922-934. PMID: 28064308.
  48. Wang Y, Santerre M, Tempera I, Martin K, Mukerjee R, Sawaya BE. Hiv-1 Vpr Disrupts Mitochondria Axonal Transport and Accelerates Neuronal Aging. Neuropharmacology. 2017;117:364-375. PMID: 28212984.
  49. Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW. Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: An Institutional Experience. Endocrine pathology. 2016;27(4):359-362. PMID: 27379493.
  50. Wierda WG, Zelenetz AD, Gordon LI, et al. Nccn Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(3):293-311. PMID: 28275031.
  51. Wiest DL. Themis-Tery Is Solved. Nature immunology. 2017;18(4):368-370. PMID: 28323266.
  52. Yoon SM, Shaikh T, Hallman M. Therapeutic Management Options for Stage Iii Non-Small Cell Lung Cancer. World journal of clinical oncology. 2017;8(1):1-20. PMID: 28246582. PMC5309711.
  53. Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. Astro Apex(R) and Ro-Ils Are Applicable to Medical Malpractice in Radiation Oncology. Future oncology (London, England). 2016;12(22):2643-2657. PMID: 27470145.
  54. Zaorsky NG, Showalter TN, Ezzell GA, et al. Acr Appropriateness Criteria® External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer, Part I of Ii. Advances in Radiation Oncology. 2017;2(1):62-84.
  55. Zawistowski JS, Bevill SM, Goulet DR, et al. Enhancer Remodeling During Adaptive Bypass to Mek Inhibition Is Attenuated by Pharmacologic Targeting of the P-Tefb Complex. Cancer discovery. 2017;7(3):302-321. PMID: 28108460. PMC5340640.
  56. Zhang FF, Haslam DE, Terry MB, et al. Dietary Isoflavone Intake and All-Cause Mortality in Breast Cancer Survivors: The Breast Cancer Family Registry. Cancer. 2017. PMID: 28263368.
  57. Zijoo R, von Mehren M. Efficacy of Trabectedin for the Treatment of Liposarcoma. Expert opinion on pharmacotherapy. 2016;17(14):1953-1962. PMID: 27615729.
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s